Clinical Trial Update: Efficacy, Safety, and Immunogenicity of the Bivalent Inactivated Enterovirus Vaccine (Vero Cell) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating the efficacy, safety, and immunogenicity of a bivalent inactivated enterovirus vaccine (Vero cell) for Hand, Foot, an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand Foot and Mouth Disease

Drugs mentioned

• Bivalent Inactivated Enterovirus Vaccine (Vero Cell) (enterovirus vaccine, inactivated, bivalent (Vero cell-derived))

Snippet

Sponsor: Sinovac Biotech Co., Ltd | Conditions: Hand, Foot, and Mouth Disease（HFMD) | Phase 3 | Status: RECRUITING